Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
暂无分享,去创建一个
F. Couch | J. Palmer | C. Haiman | E. John | P. Kraft | H. Anton-Culver | K. Nathanson | L. Bernstein | A. Trentham-Dietz | S. Yao | E. Polley | S. Domchek | S. Hart | C. Ambrosone | T. Pal | D. Goldgar | E. Bandera | Hongyan Huang | D. Sandler | Chunling Hu | J. Weitzel | K. Bertrand | M. Gaudet | Chi Gao | Jie Na | T. Bethea | L. LeMarchand | P. Shah | S. Yadav | Rohan D Gnanaolivu | Kun Y. Lee | W. Yang | W. Yang | W. Yang | J. Palmer
[1] A. Jemal,et al. Cancer statistics for African Americans, 2019 , 2019, CA: a cancer journal for clinicians.
[2] A. Whittemore,et al. Enrollment and biospecimen collection in a multiethnic family cohort: the Northern California site of the Breast Cancer Family Registry , 2019, Cancer Causes & Control.
[3] T. Walsh,et al. Inherited Breast Cancer in Nigerian Women , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Raymond M. Moore,et al. Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing , 2018, Journal of the National Cancer Institute.
[5] Raymond M. Moore,et al. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer , 2018, JAMA.
[6] Annette Lee,et al. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations , 2018, Human mutation.
[7] C. Weinberg,et al. The Sister Study Cohort: Baseline Methods and Participant Characteristics , 2017, Environmental health perspectives.
[8] Robert Huether,et al. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer , 2017, JAMA oncology.
[9] M. McCullough,et al. The American Cancer Society's Cancer Prevention Study 3 (CPS‐3): Recruitment, study design, and baseline characteristics , 2017, Cancer.
[10] Gayle Patel,et al. A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes , 2017, Cancer.
[11] R. Jagsi,et al. Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M. Daly,et al. A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer. , 2016, Cancer discovery.
[13] S. Domchek,et al. Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] K. Nathanson,et al. Population Frequency of Germline BRCA1/2 Mutations. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Jianxin Shi,et al. Developing and evaluating polygenic risk prediction models for stratified disease prevention , 2016, Nature Reviews Genetics.
[16] M. Akbari,et al. Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas , 2016, Clinical genetics.
[17] E. Boerwinkle,et al. dbNSFP v3.0: A One‐Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice‐Site SNVs , 2016, Human mutation.
[18] Wendy K Chung,et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing , 2015, Genetics in Medicine.
[19] A. Monteiro,et al. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida , 2015, Cancer.
[20] Ricardo Villamarín-Salomón,et al. ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..
[21] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[22] Nazneen Rahman,et al. CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting , 2015, Genome Medicine.
[23] Steven N. Hart,et al. VCF-Miner: GUI-based application for mining variants and annotations stored in VCF files , 2015, Briefings Bioinform..
[24] Nazneen Rahman,et al. Gene-panel sequencing and the prediction of breast-cancer risk. , 2015, The New England journal of medicine.
[25] Aniruddh Kashyap,et al. Germline RECQL mutations are associated with breast cancer susceptibility , 2015, Nature Genetics.
[26] R. Jagsi,et al. Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Brigitte Rack,et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Nazneen Rahman,et al. Breast-cancer risk in families with mutations in PALB2. , 2014, The New England journal of medicine.
[29] D. Miglioretti,et al. Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case–control studies , 2014, Breast Cancer Research and Treatment.
[30] Steven N. Hart,et al. The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation , 2014, Bioinform..
[31] Jürgen Sauter,et al. Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing , 2014, BMC Genomics.
[32] R. Baer. Luring BRCA1 to the scene of the crime. , 2013, Cancer cell.
[33] S. Cross,et al. CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] X. Ye,et al. Increased risk of breast cancer in women with NF1 , 2012, American journal of medical genetics. Part A.
[35] C. Rotimi,et al. Genetic Susceptibility Loci for Subtypes of Breast Cancer in an African American Population , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[36] O. Olopade,et al. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients , 2012, International journal of cancer.
[37] R. Tothill,et al. Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles , 2012, PLoS genetics.
[38] C. Begg,et al. Rare germline mutations in PALB2 and breast cancer risk: A population‐based study , 2012, Human mutation.
[39] C. Eng,et al. Lifetime Cancer Risks in Individuals with Germline PTEN Mutations , 2012, Clinical Cancer Research.
[40] Deborah Hughes,et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer , 2011, Nature Genetics.
[41] P. Oefner,et al. Rare variants in the ATM gene and risk of breast cancer , 2011, Breast Cancer Research.
[42] Douglas E Levy,et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk , 2011, Genetics in Medicine.
[43] Dieter Niederacher,et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene , 2010, Nature Genetics.
[44] B. Dunn,et al. Health disparities in breast cancer: biology meets socioeconomic status , 2010, Breast Cancer Research and Treatment.
[45] H. Valdimarsdottir,et al. Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women , 2009, Journal of oncology.
[46] P. Fasching,et al. Update on Anti-EGFR Therapy , 2009, Journal of oncology.
[47] S. Sommer,et al. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] Alice S Whittemore,et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. , 2007, JAMA.
[49] Giske Ursin,et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. , 2006, Cancer research.
[50] Nazneen Rahman,et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles , 2006, Nature Genetics.
[51] L. Esserman,et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.
[52] B. Haffty,et al. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women , 2005, Journal of Medical Genetics.
[53] M. Putt,et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. , 2005, JAMA.
[54] M. King,et al. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.
[55] T. Ohta,et al. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[56] Hoda Anton-Culver,et al. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States) , 2002, Cancer Causes & Control.
[57] B. Ward,et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] M. Thun,et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort , 2002, Cancer.
[59] C Caldas,et al. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. , 2001, Gastroenterology.
[60] A. Ziogas,et al. Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer. , 2000, European journal of cancer.
[61] D O Stram,et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. , 2000, American journal of epidemiology.
[62] J. Palmer,et al. The Black Women's Health Study: a follow-up study for causes and preventions of illness. , 1995, Journal of the American Medical Women's Association.
[63] James P Evans,et al. Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[64] Dee W. West,et al. Prevalence of Pathogenic BRCA 1 Mutation Carriers in 5 US Racial / Ethnic Groups , 2007 .
[65] C. Boring,et al. Cancer statistics for african americans , 1992, CA: a cancer journal for clinicians.